Warning: setcookie() expects parameter 3 to be integer, array given in /web/htdocs2/remiontesztszerverinfo/home/www/wp-content/plugins/uncode-privacy/includes/class-uncode-toolkit-privacy-public.php on line 99 Services EN – Methylex
Uniquely high clinical evidence is now available for customers to improve their cancer risk prevention actions (early detection, localization, monitoring of recurrence) and/or anti-cancerous biomedical investigation activities (drug and/or therapeutic response, prediction of efficacy). Methylex solution is cost effective and requires only standard laboratory equipment. We are providing onsite services worldwide however the computational analysis as complementary service is performed completely online.
Share the scopeEstablish a conversation and let us meet Your research goals and service requiremets
Define metrics Let us meet virtually or in person to discuss the number of samples and the depth of their analysis along Your R&D&I goals
Set-up timingGet a tailored offer from us, study the terms and conditions together and agree on the details on a mutual benefit
Kick-offPlace the order and verify Your concept with an exceptionally high clinical evidence
OUR EPIGENETIC SOLUTION HAS SEVERAL ADVANTAGES COMPARED TO TRADITIONAL GENETIC TOOLS
uniquely high accuracy
and quality control
low amount of input DNA
high sensitivity and specificity,
even at low sequence depth
bisulfite-free method avoiding
the loss of critical information
challenges the overcome limitations of the current analytical standards
scalability to multiple scopes and cancer types
wet lab technique can be performed locally using existing infrastructure
performing the wet lab technique only requires standard equipment
results within short timeframe at reasonable costs
robust analytical power for demonstrations of drug and therapeutic efficacy
can be used as the foundation of personalized cancer diagnosis and treatment strategies
potential in other diseases than cancer
METHYLEX VALUE-ADD IS SCALABLE AT MULTIPLE LEVELS
Methylex method helps to evaluate methylation complexity with upscaled classification accuracy.
Epigenome-wide mapping of DNA methylation related information can be reached without investing in costly ICT infrastructure.
Bigdata-driven setting performs efficient one-time instance tailoring on large datasets for various research scopes.
We provide an advanced depth of molecular epigenetic analysis.
We have identified a new potential of disease profiling by reading and analyzing at least ten times more data than the recent standards on the market.
Methylex technique is flexibly adoptable as a uniquely precise detection and localization technique for laboratory medicine practices.
DNA methylation related epigenetic alterations (ep-mutations) proved us specific signals conserved across individuals and among clinical groups.
Methylex workflow can be used as a powerful verification tool of drug response.
Our analysis of epigenetic modifications has a higher sensitivity and stability compared with the recently applied techniques.
Identification of methylation patterns are built up from billions of epigenetic data.
Methylex technology is a leading-edge approach includes a possible game-changing accuracy in disease-specific information.
Our bigdata-driven tool works with flexibly scalable analytical model during the clinical evaluation of such therapeutic products.
METHYLEX SOLUTION HAS A GREAT POTENTIAL IN THE TREATMENT OF DISEASES OTHER THAN CANCER
Our technique could be used to diagnose and predict the outcome or monitor the development of more human diseases resulting a higher probability of a successful treatment of the patients. We are continuously developing our solution to extend its advantages in the near future, especially in the following fields.
We are offering flexible on-site services covering the molecular epigenetic data collection and bioinformatic preprocessing. Our workflow mitigates quality-control risks where the sequencing steps need input datasets in a very high-quality. Methylex solution supports researches on customers facilities. Computational analysis can be ordered as an additional service or performed in a collaborative manner.
Epigenetic data-driven health services unlock the potential of early detection and monitoring of diseases. We are currently working on Methylex diagnostic labels to provide affordable and easy-accessible medical tests at a wide range for the global society. We are also opened to cooperate with public- or private healthcare units to design their own DNA-methylation related laboratory settings in various medical fields.
Methylex analysis from raw files establishes powerful analytical tool where reports are tailored to customer requirements. Our solution unlocks sufficient sensitivity of drug response specific information. Reports are based on a possibly game-changing depth of clinical evidence. Robust demonstrations can be achieved within a short timeframe at reasonable costs.
Methylex is providing exceptionally accurate demonstration of the onco-therapeutic response of particular patient clusters. We utilize DNA methylation-driven epigenetic marks to return invaluable information for our customers during the clinical evaluation of their onco-therapeutic products.